hotspot -WSS

hotspot

author：fashion 2025-10-01 18:34:00 - browse：6

At some point this summer, the drugmaker Novo Nordisk will release results from a closely watched study that, if successful, could further uncork demand for new obesity medications, streamline insurance coverage for the therapies, and demonstrate long-lasting health benefits.

The Select trial, as the study is called, is the first large, randomized trial to test whether long-term treatment with a weight loss drug can meaningfully improve patients’ cardiovascular health. Novo is testing Wegovy, a weekly injection also sold under the brand name Ozempic for type 2 diabetes, against placebo in the five-year study.

The implications are massive, and not just for Novo. Wegovy is part of a class of medicines that target a hormone called GLP-1, which curbs patients’ appetites. Those drugs have demonstrated an ability to help people lose dramatic amounts of weight in clinical trials, but payers, including Medicare, have been slow to reimburse for them without definitive data on their long-term health benefits.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： Readout LOUD podcast: possible new ALS drug, artificial wombs

WSS

Retired US general questions alleged Putin, Prigozhin meeting

Elizabeth Holmes on track for early release from her 11

Oak trusses raised to roof of fire

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

entertainment

hotspot

focus

Continuity nursing helped my family in our darkest PICU moments

What to know about OceanGate, the company behind the missing Titanic submersible

Affirmative action in medical school literally saved lives

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

23andMe had bad news about my health. I wish a person had delivered it

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

Sports medicine is finally prioritizing gender equality

Leqembi, other new Alzheimer’s drugs require better biomarkers

The cancer drug shortage isn’t new — and neither are the solutions

EpiPen alternative approval delay highlights citizen petition issue

entertainment

Living with Fabry disease, a condition that causes chronic pain

Readout LOUD podcast: possible new ALS drug, artificial wombs

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

Drug for rare kidney disease narrowly misses mark in clinical trial

Hearing on Medicare drug price negotiation gets unusually heated

How AI helped researchers track recovery from depression

focus

Wikipedia

hotspot

hotspot